Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/06/2014US20140037625 Biomarkers and methods of treatment
02/06/2014US20140037622 Human papilloma virus as predictor of cancer prognosis
02/06/2014US20140037620 Methods of Treating Breast Cancer with Gemcitabine Therapy
02/06/2014US20140037617 Kinase modulation, and indications therefor
02/06/2014US20140037604 Nutritional compositions comprising alpha-hydroxyisocaproic acid
02/06/2014US20140037603 Nutritional compositions including branched chain fatty acids for improving gut barrier function
02/06/2014US20140037602 Nutritional compositions including branched chain fatty acids and methods of using same
02/06/2014US20140037601 Nutritional compositions including branched chain fatty acids for wound healing
02/06/2014US20140037597 Sulfated Depolymerized Derivatives of Exopolysaccharides (EPS) From Mesophilic Marine Bacteria, Method For Preparing Same, And Uses Thereof In Tissue Regeneration
02/06/2014US20140037589 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
02/06/2014US20140037587 Beneficial effects of bacteriophage treatments
02/06/2014US20140037583 Methods and compositions suitable for preventing and treating hyperleptinemia
02/06/2014US20140037580 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
02/06/2014US20140037577 Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
02/06/2014US20140037576 P2X7: Inhibition Of Epithelial Cancers and Papillomas
02/06/2014US20140037574 Pharmaceutical composition
02/06/2014US20140037573 Conjugates, particles, compositions, and related methods
02/06/2014US20140037550 Colchicine compositions and methods
02/06/2014US20140037548 Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors
02/06/2014US20140035184 Extended release biodegradable ocular implants
02/06/2014US20140034873 Buffered compositions for dialysis
02/06/2014DE102013011399A1 Rod-shaped biodegradable implant useful for maintenance therapy in schizophrenia in patients comprises risperidone
02/06/2014CA2876246A1 Substituted pyrazolone compounds and methods of use
02/05/2014EP2693259A1 Lens incorporating myopia control optics and muscarinic agents
02/05/2014EP2692862A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
02/05/2014EP2692777A1 Pharmaceutical composition containing block copolymer comprising boric acid compound
02/05/2014EP2692742A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
02/05/2014EP2692728A1 Novel furanone derivative
02/05/2014EP2692727A2 Novel oxazolidinone derivative and medical composition containing same
02/05/2014EP2692726A1 Anti-viral compounds
02/05/2014EP2692725A1 Method for producing phenoxypyridine derivative
02/05/2014EP2692724A1 Chiral 3-hydroxypyrid-4-one derivative, and synthesis and use thereof
02/05/2014EP2692719A1 Method for preparing creatine fatty esters, creatine fatty esters thus prepared and uses thereof
02/05/2014EP2692360A1 Fat emulsion containing prostaglandin
02/05/2014EP2692351A1 Active fraction of paullinia cupana with improved activity against fatigue, method for producing an active fraction, use, pharmaceutical composition, medicament and method for the treatment of fatigue
02/05/2014EP2692347A1 Ointment with excellent formulation stability
02/05/2014EP2692346A1 An antiviral 1-phenyl-2,5-dibenzimidazol-5-yl-pyrrolidine derivative
02/05/2014EP2692345A2 Pharmaceutical composition for preventing or treating macular degeneration
02/05/2014EP2692344A1 Combination therapy for treatment of Multiple sclerosis
02/05/2014EP2692343A1 Combination therapy for treatment of multiple sclerosis
02/05/2014EP2692342A1 Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets
02/05/2014EP2692341A1 Abuse resistant drug formulation
02/05/2014EP2692340A1 Stable pharmaceutical system (kit) for the preparation of oral solution of levothyroxine or pharmaceutically acceptable salt thereof
02/05/2014EP2692332A2 Composition for the treatment of callus, corns, moles, telangiectasias, and psoriasis
02/05/2014EP2691548A2 Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy
02/05/2014EP2691527A1 Aptamers that are specific for immunoglobulin-binding cell wall proteins
02/05/2014EP2691525A1 Treatment and prognosis of solid tumour cancers
02/05/2014EP2691409A1 Compounds and pharmaceutical compositions for the treatment of viral infections
02/05/2014EP2691407A1 Selective glycosidase inhibitors and uses thereof
02/05/2014EP2691403A1 New boranophosphate analogues of cyclic nucleotides
02/05/2014EP2691402A1 Bifunctional hydroxy-bisphosphonic acid derivatives
02/05/2014EP2691399A1 Thiazolopyrimidine compounds
02/05/2014EP2691397A2 Methods and compositions for preparing noribogaine from voacangine
02/05/2014EP2691396A2 Enopeptins, uses thereof, and methods of synthesis thereto
02/05/2014EP2691395A1 Processes for preparing tofacitinib salts
02/05/2014EP2691394A1 Compounds for treatment of metabolic syndrome
02/05/2014EP2691393A1 Novel bicyclic pyridinones
02/05/2014EP2691392A1 Imidazo [1,2-a]pyridine compounds for use in therapy
02/05/2014EP2691391A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases
02/05/2014EP2691390A1 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide
02/05/2014EP2691389A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
02/05/2014EP2691388A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
02/05/2014EP2691387A2 Process for the preparation of anhydrous aripiprazole crystal form ii
02/05/2014EP2691384A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
02/05/2014EP2691377A1 Aminoquinoxaline derivatives for treatment of neurodegenerative diseases
02/05/2014EP2691376A1 Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
02/05/2014EP2691375A1 Substituted benzimidazoles
02/05/2014EP2691373A1 3-ureidoisoquinolin-8-yl derivatives
02/05/2014EP2691372A1 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
02/05/2014EP2691371A1 Benzoic acid salt of otamixaban
02/05/2014EP2691370A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan
02/05/2014EP2691368A1 Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
02/05/2014EP2691120A2 Theranostic imaging agents and methods of use
02/05/2014EP2691109A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
02/05/2014EP2691101A2 Delivery and formulation of engineered nucleic acids
02/05/2014EP2691100A2 Intranasal benzodiazepine pharmaceutical compositions
02/05/2014EP2691099A1 Methods of targeted treatment of frontotemporal lobar degeneration
02/05/2014EP2691098A1 Trpm5 inhibitors support body weight reduction without reducing food intake
02/05/2014EP2691097A1 Compositions of opioid antagonists and their use for treating scleroderma
02/05/2014EP2691096A1 Pouch containing nicotine in free salt form
02/05/2014EP2691095A2 Imidazolyl amide compounds and uses related thereto
02/05/2014EP2691094A1 Alisporivir to treat hepatitis c virus infection
02/05/2014EP2691093A1 Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
02/05/2014EP2691092A2 Use of compounds isolated from morus bark
02/05/2014EP2691091A1 Use of epigallocatechin gallate as an antiviral agent against infections by the hepatitis c virus
02/05/2014EP2691090A2 Tight junctions modulators
02/05/2014EP2691089A1 Nutritional compositions for increasing arginine levels and methods of using same
02/05/2014EP2691088A1 Viral inhibitor composition for in vivo therapeutic use
02/05/2014EP2691087A2 Pharmaceutical composition containing no, process for the preparation and use thereof
02/05/2014EP2691086A1 Compositions for the treatment of neurologic disorders
02/05/2014EP2691085A1 Film-forming composition for a ph-dependant sustained release of the active agent
02/05/2014EP2691083A1 Pharmaceutical composition of sitagliptin
02/05/2014EP2691081A1 Sustained-release injectable formulation
02/05/2014EP2691080A1 Menthol liquids composition
02/05/2014EP2691077A1 Salicylic acid topical formulation
02/05/2014EP2691076A1 Usnic acid topical formulation
02/05/2014EP2691075A1 Otamixaban formulations with improved stability
02/05/2014CN203417347U Oral microparticle of citrus young fruit extract
02/05/2014CN103562379A Cell differentiation inducer and differentiation inducing method
02/05/2014CN103562212A Method for manufacturing phosphonocrotonic acid derivative
1 ... 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 ... 7860